1
|
Roccuzzo G, Macagno N, Sarda C, Pisano J, Ribero S, Fava P, Quaglino P. Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic. Acta Derm Venereol 2024; 104:adv40505. [PMID: 39007462 DOI: 10.2340/actadv.v104.40505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2024] [Accepted: 06/25/2024] [Indexed: 07/16/2024] Open
Abstract
is missing (Short communication).
Collapse
Affiliation(s)
| | - Nicole Macagno
- Department of Medical Sciences University of Turin, Turin, Italy
| | - Cristina Sarda
- Department of Medical Sciences University of Turin, Turin, Italy
| | - Jelena Pisano
- Department of Medical Sciences University of Turin, Turin, Italy
| | - Simone Ribero
- Department of Medical Sciences University of Turin, Turin, Italy
| | - Paolo Fava
- Department of Medical Sciences University of Turin, Turin, Italy
| | - Pietro Quaglino
- Department of Medical Sciences University of Turin, Turin, Italy
| |
Collapse
|
2
|
Gordon ER, Trager MH, Kwinta BD, Stonesifer CJ, Lee KJ, Adeuyan O, Lapolla BA, Akilov OE, Enz PA, Guenova E, Ortiz-Romero PL, Papadavid E, Quaglino P, Rozati S, Scarisbrick JJ, Litman T, Geskin LJ. Maintenance therapy for CTCL: importance for prevention of disease progression. Leuk Lymphoma 2024:1-8. [PMID: 38975910 DOI: 10.1080/10428194.2024.2376164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Accepted: 06/30/2024] [Indexed: 07/09/2024]
Abstract
There are no established maintenance protocols for cutaneous lymphomas. We aim to determine patient treatments and outcomes during the COVID-19 pandemic in order to uncover the most effective maintenance protocols for cutaneous lymphomas and impact of treatment interruption. Data was collected retrospectively from nine international institutions, including 149 patients. Younger patients had earlier stages of disease and were most frequently treated with skin-directed therapies including topical steroids, mechlorethamine gel, and phototherapy. Treatment interruption varied by treatment type and stage, with patients on topical therapies and earlier stages of disease being least likely to experience interruption. Treatment interruption was significantly associated with progression of disease and worse outcomes, with twice as many patients progressing who had interruption compared to those without interruption. This study may demonstrate the significance of continuous maintenance therapies, even in younger patients with early stages of disease.
Collapse
Affiliation(s)
- Emily R Gordon
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
| | - Megan H Trager
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Bradley D Kwinta
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Connor J Stonesifer
- Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Kaitlyn J Lee
- Division of Biostatistics, UC Berkeley School of Public Health, Berkeley, CA, USA
| | - Oluwaseyi Adeuyan
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
| | - Brigit A Lapolla
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| | - Oleg E Akilov
- Cutaneous Lymphoma Program, University of Pittsburgh, Pittsburgh, PA, USA
| | - Paula A Enz
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Emmanuella Guenova
- Department of Dermatology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland
| | - Pablo L Ortiz-Romero
- Hospital 12 de Octubre, Institute i + 12, CIBERONC, Medical School, University Complutense, Madrid, Spain
| | - Evangelia Papadavid
- Attikon General University Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - Pietro Quaglino
- Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy
| | - Sima Rozati
- Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Julia J Scarisbrick
- Department of Dermatology, University Hospital Birmingham, Birmingham, United Kingdom
| | - Thomas Litman
- Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
| | - Larisa J Geskin
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
3
|
Levy Yurkovski I, Rokach L, Melamed G, Alapi H, Gazit S, Patalon T, Tadmor T. Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome. Acta Haematol 2023; 146:496-503. [PMID: 37517402 PMCID: PMC11251663 DOI: 10.1159/000531831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Accepted: 06/28/2023] [Indexed: 08/01/2023]
Abstract
INTRODUCTION Haemato-oncologic patients are more susceptible to severe infections with SARS-CoV-2. We aimed to assess the clinical outcomes of SARS-CoV-2 infection among patients with Mycosis Fungoides and Sezary Syndrome (MF/SS). METHODS The data were retrieved from anonymized electronic medical records of Maccabi Healthcare Services (MHS), the second-largest healthcare organization in Israel. Patients diagnosed with MF/SS were included in the study. COVID-19 PCR test results together with sociodemographic and clinical data were extracted and analyzed to evaluate the association of COVID-19 with clinical outcomes. RESULTS In the period of 2020-2022, 1,472 MF/SS patients were included in the study. Among them, 768 (52%) had SARS-CoV-2 infection. The hospitalization rate was 2.9% and infection by the Delta variant was associated with the highest hospitalization rate (7.7%). The hospitalization rate was lower among fully vaccinated patients (p = 0.032) but higher for patients older than 65 (p < 0.001) and patients with SS (vs. MF) (p < 0.001) or COPD (p = 0.024) diagnosis. There was a tendency for decreased hospitalization among patients treated with nirmatrelvir + ritonavir within 5 days of infection, with a 79% risk reduction, although it was not statistically significant (p = 0.164). CONCLUSION Patients with MF/SS do not necessarily have worse COVID-19 outcomes compared to the general population.
Collapse
Affiliation(s)
- Ilana Levy Yurkovski
- Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
- Technion Israel Institute of Technology, Haifa, Israel
| | - Lior Rokach
- Department of Information Systems Engineering, Faculty of Engineering Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - Guy Melamed
- Kahn Sagol Maccabi (KSM) Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
| | - Hillel Alapi
- Kahn Sagol Maccabi (KSM) Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
| | - Sivan Gazit
- Kahn Sagol Maccabi (KSM) Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
| | - Tal Patalon
- Kahn Sagol Maccabi (KSM) Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
| | - Tamar Tadmor
- Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
- Technion Israel Institute of Technology, Haifa, Israel
| |
Collapse
|
4
|
Oliveira ÉVL, Landell LM, Souza CDS. Recurrence of controlled mycosis fungoides after SARS-CoV-2 infection. An Bras Dermatol 2023; 98:120-122. [PMID: 36376118 PMCID: PMC9554330 DOI: 10.1016/j.abd.2022.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2022] [Revised: 06/07/2022] [Accepted: 06/09/2022] [Indexed: 01/19/2023] Open
Affiliation(s)
- Éderson Valei Lopes Oliveira
- Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Faculty of Medicine, Universidade de São Paulo, Ribeirão Preto, SP, Brazil,Corresponding author
| | - Lígia M. Landell
- Department of Pathology and Forensic Medicine, Ribeirão Preto Faculty of Medicine, Universidade de São Paulo, Ribeirão Preto, SP, Brazil,Laboratory of Pathology Prof. Dr. Humberto de Queiroz, Ribeirão Preto, SP, Brazil
| | - Cacilda da Silva Souza
- Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Faculty of Medicine, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
| |
Collapse
|
6
|
Costa FB, Baptista PL, Duquia RP. A cross-sectional questionnaire study in a phototherapy unit during COVID-19. Photochem Photobiol Sci 2021; 20:1239-1242. [PMID: 34449079 PMCID: PMC8393778 DOI: 10.1007/s43630-021-00093-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Accepted: 08/17/2021] [Indexed: 11/29/2022]
Abstract
Background In March 2020, social isolation measures were imposed in Brazil to contain the spread of the novel coronavirus (SARS-CoV-2), requiring health services to implement contingency plans. The main objective of the study was to verify the status of the disease, self-reported by patients who discontinued phototherapy, during a period of social isolation. Methods All patients receiving phototherapy at the Santa Casa de Porto Alegre, Brazil, prior to the implementation of social distancing measures were eligible for inclusion in the study. 86 patients answered a questionnaire during a medical evaluation. Results 95% of patients who stopped phototherapy reported a worsening of disease status. Only 19% of patients continued to attend phototherapy sessions during the social isolation period. Conclusion The COVID-19 pandemic led most patients to stop phototherapy, resulting in the perception of increased disease severity in an outpatient sample in southern Brazil.
Collapse
Affiliation(s)
- Francine Batista Costa
- Department of Dermatology, Santa Casa de Misericórdia de Porto Alegre, 135, Annes Dias St., Porto Alegre, Rio Grande Do Sul, RS, 90040-001, Brazil.
| | - Patrícia Lima Baptista
- Department of Dermatology, Santa Casa de Misericórdia de Porto Alegre, 135, Annes Dias St., Porto Alegre, Rio Grande Do Sul, RS, 90040-001, Brazil
| | - Rodrigo Pereira Duquia
- Department of Dermatology, Santa Casa de Misericórdia de Porto Alegre, 135, Annes Dias St., Porto Alegre, Rio Grande Do Sul, RS, 90040-001, Brazil
| |
Collapse
|